Management

Richard  J. Daly
President and Chief Executive Officer
Richard  J. Daly
President and Chief Executive Officer


Mr. Richard J. Daly is the President, Chief Executive Officer and Director of Neuralstem, a position he has held since February 2016. Mr. Daly’s career of commercial pharmaceutical leadership experience spans over 25 years and encompasses strategy, sales, marketing, and operations. Prior to joining Neuralstem, he served as Managing Director of Ravine Rock Partners, LLC, a healthcare commercial performance acceleration firm where his expertise was leveraged as the Interim CCO of Catalyst Pharma u... 
Dr.  Karl Johe, Ph.D.
Chief Scientific Officer
Dr.  Karl Johe, Ph.D.
Chief Scientific Officer


Dr. Karl Johe, Ph.D. has been a director, Chairman of the Board and Chief Scientific Officer of Neuralstem, Inc. since 1996. Dr. Johe has more than 15 years of research and laboratory experience. Dr. Johe is the sole inventor of Neuralstem’s stem cell patents and is responsible for the strategic planning and development of the Company’s therapeutic products. Dr. Johe received his Bachelor of Arts Degree in Chemistry and a Master’s Degree from the University of Kansas. Dr. Johe received his docto... 
Thomas G. Hazel Ph.D.
Senior Vice President, Research
Thomas G. Hazel Ph.D.
Senior Vice President, Research


Dr. Thomas G. Hazel, Ph.D. has served as Neuralstem’s Senior Vice President, Research since 2008 and previously as the Company’s Stem Cell Discovery Program Director from 2000-2004, and Senior Scientist from 1998-2000. Dr. Hazel received his doctorate in Genetics from the University of Illinois College of Medicine, and a Bachelor of Arts in Biology from Kalamazoo College. Dr. Hazel was Staff Scientist at the NIH Laboratory of Molecular Biology of the National Institute of Neurological Disorders ...